CRP and histiocytic sarcoma: HiSCR was achieved by more than half the patient cohort, a significant reduction from baseline was observed for the number of all HS lesions (inflammatory nodules, abscesses, and drainage fistulas), general overall improvement status of “improved” was reported for almost all patients, NRS and DLQI were significantly improved from baseline, and CRP levels significantly decreased, indicating a reduction in inflammation.